Kim, Jung-Min
Yang, Yeon-Suk
Park, Kwang Hwan
Ge, Xianpeng
Xu, Ren http://orcid.org/0000-0001-6578-4553
Li, Na
Song, Minkyung
Chun, Hyunho
Bok, Seoyeon
Charles, Julia F. http://orcid.org/0000-0002-5875-314X
Filhol-Cochet, Odile http://orcid.org/0000-0003-1964-7958
Boldyreff, Brigitte
Dinter, Teresa
Yu, Paul B. http://orcid.org/0000-0003-2145-4944
Kon, Ning
Gu, Wei http://orcid.org/0000-0002-1480-2368
Takarada, Takeshi http://orcid.org/0000-0002-2363-7704
Greenblatt, Matthew B.
Shim, Jae-Hyuck http://orcid.org/0000-0002-4947-3293
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068983, R21AR072836, R21AR073331)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Burroughs Wellcome Fund
U.S. Department of Defense (NF150055)
March of Dimes Canada
Article History
Received: 2 March 2019
Accepted: 10 April 2020
First Online: 8 May 2020
Competing interests
: J.H.S. is a scientific founder of the AAVAA Therapeutics and holds equity in this company. Other authors declare no competing interests.